Literature DB >> 15082108

Thimerosal and autism? A plausible hypothesis that should not be dismissed.

Mark F Blaxill1, Lyn Redwood, Sallie Bernard.   

Abstract

The autism-mercury hypothesis first described by Bernard et al. has generated much interest and controversy. The Institute of Medicine (IOM) reviewed the connection between mercury-containing vaccines and neurodevelopmental disorders, including autism. They concluded that the hypothesis was biologically plausible but that there was insufficient evidence to accept or reject a causal connection and recommended a comprehensive research program. Without citing new experimental evidence, a number of observers have offered opinions on the subject, some of which reject the IOM's conclusions. In a recent review, Nelson and Bauman argue that a link between the preservative thimerosal, the source of the mercury in childhood vaccines, is improbable. In their defense of thimerosal, these authors take a narrow view of the original hypothesis, provide no new evidence, and rely on selective citations and flawed reasoning. We provide evidence here to refute the Nelson and Bauman critique and to defend the autism-mercury hypothesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15082108     DOI: 10.1016/j.mehy.2003.11.033

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  7 in total

1.  A prospective assessment of porphyrins in autistic disorders: a potential marker for heavy metal exposure.

Authors:  David A Geier; Mark R Geier
Journal:  Neurotox Res       Date:  2006-08       Impact factor: 3.911

2.  Autism spectrum disorder phenotypes and prenatal exposure to methylmercury.

Authors:  Edwin van Wijngaarden; Philip W Davidson; Tristram H Smith; Katie Evans; Kelley Yost; Tanzy Love; Sally W Thurston; Gene E Watson; Grazyna Zareba; Christine M Burns; Conrad F Shamlaye; Gary J Myers
Journal:  Epidemiology       Date:  2013-09       Impact factor: 4.822

3.  The plausibility of a role for mercury in the etiology of autism: a cellular perspective.

Authors:  Matthew Garrecht; David W Austin
Journal:  Toxicol Environ Chem       Date:  2011-05-20       Impact factor: 1.437

4.  A comparison of urinary mercury between children with autism spectrum disorders and control children.

Authors:  Barry Wright; Helen Pearce; Victoria Allgar; Jeremy Miles; Clare Whitton; Irene Leon; Jenny Jardine; Nicola McCaffrey; Rob Smith; Ian Holbrook; John Lewis; David Goodall; Ben Alderson-Day
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

Review 5.  Abnormalities in the zinc-metalloprotease-BDNF axis may contribute to megalencephaly and cortical hyperconnectivity in young autism spectrum disorder patients.

Authors:  Jae-Young Koh; Joon Seo Lim; Hyae-Ran Byun; Min-Heui Yoo
Journal:  Mol Brain       Date:  2014-09-03       Impact factor: 4.041

Review 6.  Fetal origins of autism spectrum disorders: the non-associated maternal factors.

Authors:  Hind N Moussa; Anand Srikrishnan; Sean C Blackwell; Pramod Dash; Baha M Sibai
Journal:  Future Sci OA       Date:  2016-03-21

7.  Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal.

Authors:  Thomas M Burbacher; Danny D Shen; Noelle Liberato; Kimberly S Grant; Elsa Cernichiari; Thomas Clarkson
Journal:  Environ Health Perspect       Date:  2005-08       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.